Gå till innehåll

Kommersiellt obunden läkemedelsinformation riktad till läkare och sjukvårdspersonal

Oxytetracycline

Summary

Persistence. It cannot be excluded that oxytetracycline is persistent, due to the lack of data.
Bioaccumulation. It cannot be excluded that oxytetracycline bioaccumulates, due to the lack of data.
Toxicity. It cannot be excluded that oxytetracycline is toxic, due to the lack of data.
Risk. Risk of environmental impact of oxytetracycline cannot be excluded, due to the lack of environmental toxicity data.


This summary information for oxytetracycline comes from Fass. It is voluntary for manufacturers to provide information on environmental impact on fass.se.


For antibiotics in general, it is recommended that these pharmaceuticals are used as restrictively as possible without jeopardise the patient's health.

Detailed information

Fass environmental information

Fass environmental information for Terracortril (hydrocortisone, oxytetracycline) from Pfizer (downloaded 2022-12-09).

Hazard

Persistence: No data.

Bioaccumulation: No data.

Toxicity: No data.

Risk

Risk of environmental impact of oxytetracycline cannot be excluded, due to the lack of environmental toxicity data.

Pharmaceutial residues in the aquatic environment in Sweden

Oxytetracycline is included in the report "Pharmaceutical residues in Stockholm's water environment" and has been detected in outgoing water from wastewater treatment plants. Oxytetracycline was also analyzed in IVL's report from 2014, but was below the limits of detection. Region Stockholm analyzes for oxytetracycline. In recent years, levels have been below limits of detection.

Author: Health and Medical Care Administration, Region Stockholm